IL1B and neoplasm: In addition to that, Wu et al. demonstrated that NOB treatment successfully reduced the rate of cell proliferation by 69%, tumour incidence by 40%, tumour multiplicity by 71%, and downregulated TNF-α, IL-1β and IL-6 by 65%, 69% and 45% respectively in AOM/DSS treated mice [54].